This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Intranasal Vaccination: Rationale, Progress and Challenges
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation
Exploring a Novel Device for Nasal Drug Delivery to the Olfactory System
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
Intranasal Delivery of Thin-Film Freeze-Dried Vaccine Powders
Publications, Pharmaceutical, Device Innovations, Product Solutions
Exploring the Benefits and Future Possibilities of Nasal Drug Delivery and Drug Repos...
Webinars, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights
